Title of article
Coinfection of Toenail Onychomycosis Caused by Rhodotorula mucilaginosa and Candida glabrata in an Immunocompromised Adult: A Case Report and Literature Review
Author/Authors
Ghasemi ، Reza Student Research Committee, Faculty of Medicine - Shahid Beheshti University of Medical Sciences , Ansari ، Saham Department of Medical Parasitology and Mycology - School of Medicine - Shahid Beheshti University of Medical Sciences , Lotfali ، Ensieh Department of Medical Parasitology and Mycology - School of Medicine - Shahid Beheshti University of Medical Sciences , Shahnazian ، Zahra Student Research Committee, Faculty of Medicine - Shahid Beheshti University of Medical Sciences , Madinehzad ، Ataollah Student Research Committee, Faculty of Medicine - Shahid Beheshti University of Medical Sciences , Aliabadi ، Nikta Department of Microbiology - Islamic Azad University, Tehran Branch , Zahmatkesh ، Mohammad Mahdi Student Research Committee, Faculty of Medicine - Shahid Beheshti University of Medical Sciences
From page
199
To page
205
Abstract
Background: Rhodotorula mucilaginosa and Candida glabrata have emerged as potential pathogens, particularly in immunosuppressed hosts. This study aimed to present a case of coinfection of Candida glabrata and Rhodotorula mucilaginosa in a 35-year-old immunosuppressed female with onychomycosis on the first and second left toenails. Cases Report: Causative agents were identified according to morphology, microscopic studies, culture, and DNA molecular analysis. Candida glabrata demonstrated high minimum inhibitory concentrations against the tested antifungals except itraconazole. Moreover, Rhodotorula mucilaginosa had shown low minimum inhibitory concentrations against clotrimazole and ketoconazole at a dilution of 0.25 μg/ml. Itraconazole is administered at 200 mg twice daily for one week for toenails and as pulse treatment (for one week a month) at 5 mg/kg daily with topical clotrimazole. Conclusion: Clinical improvement was noted in the patient s clinical examination after ten months. Information about the increasing resistance to antifungal agents helps decide antifungal prophylaxis and select the empirical therapy for cancer patients.
Keywords
Onychomycosis , Rhodotorula mucilaginosa , Candida glabrata , Coinfection , Drug resistance , Antifungal agents
Journal title
Novelty in Biomedicine
Journal title
Novelty in Biomedicine
Record number
2734172
Link To Document